Laufs Rainer

A
- (LUDWIG, K., SARKIM, V., BITZAN, M., KARMALI, M. A., BOBROWSKI, C., RUDER, H., LAUFS, R., SOBOTTKA, I., PETRIC, M., KARCH, K., MÜLLER-WIEFEL, D. E.) Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome. - J. Clin. Microbiol. Vol. 40, No. 5, S. 1773-1782.
- (SCHRÖTER, M., ZÖLLNER, B., SCHÄFER, P., LANDT, O., LASS, U., LAUFS, R., FEUCHT, H.-H.) Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step light cycler method using three different pairs of hybridization probes. - J. Clin. Microbiol. Vol. 40, No. 6, S. 2046-2050.
- (SCHRÖTER, M., ZÖLLNER, B., SCHÄFER, P., REIMER, A., MÜLLER, M., LAUFS, R., FEUCHT, H.-H.) Epidemiological dynamics of hepatitis C virus among 747 german individuals: new subtypes on the advance. - J. Clin. Microbiol. Vol. 40, S. 1866-1868.
- (SCHRÖTER, M., LAUFS, R., STERNECK, M., FISCHER, L., KNÖDLER, B., SCHÄFER, P., ZÖLLNER, B., FEUCHT, H. H.) SENV-H viremia and liver transplantation: significant increase of the prevalence. - Blood Vol. 100, No. 4, S. 1518-1519.
- (LAUFS, R., POLYWKA, S., FEUCHT, H.-H., SCHRÖTER, M., ZÖLLNER, B., OEHLER, G.) Hepatitis C: Virologie, Übertragungswege, Klinik, Prävention und Therapie. - Anästhesist Vol. 51, S. 884-889.
- (SCHRÖTER, M., R. LAUFS, R., ZÖLLNER, B., KNÖDLER, B., SCHÄFER, P., FEUCHT, H.-H.) A novel DNA virus (SEN) among patients on maintenance hemodialysis: prevalence and clinical importance. - J. Clin. Virol., electronically published.
- (SCHRÖTER, M., R. LAUFS, R., ZÖLLNER, B., KNÖDLER, B., SCHÄFER, P., STERNECK, M., FISCHER, L., FEUCHT, H.-H.) Prevalence of SENV-H viraemia among healthy subjects and individuals at risk for parenterally transmitted diseases in Germany. - J. Viral. Hepat. Vol. 9, S. 455-459.
- (ALBRECHT, D., ZÖLLNER, B., FEUCHT, H.-H., LORENZEN, T., LAUFS, R., STOEHR, A., PLETTENBERG, A.) Reappearance of HIV multidrug-resistance in plasma and circulating lymphocytes after reintroduction of antiretroviral therapy. - J. Clin. Virol. Vol. 24, S. 93-98.
- (ZÖLLNER, B., PETERSEN, J., SCHÄFER, P., SCHRÖTER, M., LAUFS, R., STERNECK, M., FEUCHT, H.-H.) Subtype-dependent response of hepatitis B virus during the early phase of lamivudine treatment. - Clin. Inf. Dis. Vol. 34, S. 1273-1277.
- (LUDWIG, K., GRABHORN, E., BITZAN, M., BOBROWSKI, C., KEMPER, M. J., SOBOTTKA, I., LAUFS, R., KARCH, H., MÜLLER-WIEFEL, E.) Saliva IgM and IgA are sensitive indicator of the humoral immune response to Escherichia coli O157 lipopolysaccharide in children with enteropathic hemolytic uremic syndrome. - Pediatr. Res. Vol. 52, S. 307-313.
- (SOBOTTKA, I., BARTSCHT, K., SCHÄFER, P., WEITZEL, T., SCHOTTELIUS, J., KOCK, N., LAUFS, R.) In vitro activity of polyoxin D and nikkomycin Z against Encephalitozoon cuniculi. - Parasitol. Res. Vol. 88, S. 451-453.
- (SOBOTTKA, I., CACHOVAN, G., STÜRENBURG, E., AHLERS, M. O., LAUFS, R., PLATZER, U., MACK, D.) In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. - Antimicrob. Agents Chemother. Vol. 46, S. 4019-4021.
- (SOBOTTKA, I., CACHOVAN, G., STÜRENBURG, E., AHLERS, M. O., LAUFS, R., PLATZER, U., MACK, D.) In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. 12th ECCMID, Milan. - Clin. Microbiol. Infect. Vol. 8. (1), S. 1079.
- (STÜRENBURG, E., SOBOTTKA, I., ELSNER, H.-A., MACK, D., LAUFS, R.) Cloning and sequencing of Enterobacter aerogenes OmpC-type osmoporin mediating carbapenem resistance. - Int. J. Med. Microbiol. Vol. 291 (8), S. 649-654.
- (STÜRENBURG, E., SOBOTTKA, I., FEUCHT, H.-H., MACK, D., LAUFS, R.) 2002. Comparison of Phoenix and Vitek2 automated susceptibility test systems for ESBL detection in Escherichia coli and Klebsiella sp. Clinical isolates. - Diagn. Microbiol. Infect. Dis Vol. 47(2) (im Druck).
- (KÜHN, A., MACK, D., LAUFS, R., STÜRENBURG, E.) A novel ceftazidime-hydrolyzing CTX-M-type ß-lactamase (CTX-M-AF488377) in Klebsiella pneumoniae and Escherichia coli. - Int. J. Med. Microbiol. Vol. 292 (34), S. 125-126.
- (ZÖLLNER, B., PETERSEN, J., PUCHHAMMER-STÖCKL, E., KLETZMAYR, J., STERNECK, M., FISCHER, L., SCHODER, V., SCHRÖTER, M., SCHÄFER, P., LAUFS, R., FEUCHT, H.-H.) Predictors of emerging drug-resistant HBV during lamivudine treatment. - Antiviral Therapy Vol. 7, L86.
- (VON HARBOU, K., SCHRÖTER, M., ZÖLLNER, B., BUGGISCH, P., SEEGERS, B., DE HEER, G., STERNECK, M., LAUFS, R., FEUCHT, H.-H.) Lack of quasispecies evolution in HCV during response to therapy. - Antiviral therapy Vol. 7, L96.
- (SCHRÖTER, M., FEUCHT, H.-H., ZÖLLNER, B., SCHÄFER, P., LAUFS, R.) Multiple infections with different HCV genotypes: prevalence and clinical impact. - J. Clin. Microbiol. (Im Druck).